Publications · 2021–2025

Publications

Health publications with at least one Saudi-affiliated author, from PubMed matched with OpenAlex. A Saudi affiliation is not the same as research on the Saudi population.

Health publications with at least one Saudi-affiliated author

Choose A View

The two first-or-last-author choices overlap: a paper with a Saudi-based and a dual-affiliated lead is under both.

Year

Showing 2021–2025 · research papers only · Any Saudi author

Research publications

Each paper counts once, in the year of its earliest publication date.

Source: PubMed with OpenAlex · 2021–2025 provisional

Saudi-based first or last author

Each paper is counted once, even if the other lead is dual-affiliated. Beside it, papers whose only first or last authors with a Saudi affiliation are dual-affiliated: 10% ().

54%

of the 67,466 papers · 2021–2025 provisional

Open access

Any route in OpenAlex: diamond, gold, hybrid, green or bronze.

79%

of the 67,441 papers with an open-access status recorded · 2021–2025 provisional

Research Publications By Year

Research papers only. All publication designs, not only observational. Source: PubMed, matched with OpenAlex; papers with at least one Saudi affiliation; PubMed snapshot of 4 October 2026; OpenAlex data as of 29 October 2026.

Applies: year (year of earliest publication) and publication scope. Does not apply: Saudi-based first or last author, or lead sponsor; sponsorship is a registry field, and a paper’s industry involvement is judged separately, from author affiliations, funding statements and declared interests. Each paper counts once, in the year of its earliest publication date. This total is never added to any registration count.

2021 11,256
2022 13,080
2023 12,979
2024 13,901
2025 provisional 16,250

PubMed with OpenAlex · 2021–2025

01 / STUDY TYPES

Five Groups, Twenty-Seven Study Types

Each research paper has one study type, coded from its title and abstract under the labelling guide. The code records the design reported, not the quality of the study. Open a group to see its types.

Applies: year, publication scope and Saudi authorship. The code describes the publication, not the larger study it comes from: a qualitative paper from a trial is qualitative, and an economic paper from a trial is economic. Types are shown on their group's own scale; each paper has one type, so they sum to the group. Groups and types keep their code order.

Interventional I1–I5
I1 Randomised controlled trial
I2 Cluster or crossover RCT
I3 Non-randomised controlled trial
I4 Single-arm trial
I5 Before-and-after or quasi-experimental
Observational O1–O6
O1 Prospective cohort
O2 Retrospective cohort or chart review
O3 Case-control
O4 Cross-sectional or survey
O5 Diagnostic accuracy
O6 Case series (more than three patients)
Evidence synthesis E1–E6
E1 Systematic review
E2 Meta-analysis
E3 Scoping or mapping review
E4 Umbrella review
E5 Narrative review
E6 Guideline or consensus statement
Laboratory and animal L1–L4
L1 In vitro
L2 Animal
L3 Genetic or omics
L4 Computational
Other designs X1–X6
X1 Qualitative or mixed methods
X2 Economic evaluation or HTA
X3 Modelling or simulation
X4 AI model development
X5 Methods or measurement study
X6 Study protocol

02 / OPENALEX-NORMALISED CITATION INFLUENCE

Citation Measures By Year

Two measures from OpenAlex, each compared with the world for the same field and year: mean field-weighted citation impact (World = 1.00) and the share in the world's top tenth most cited (World = 10%), with fractional counting, by OpenAlex publication year, and nothing shown for a selection with too few papers that carry the measure. Papers without the measure are left out, never counted as zero.

Not shown. Not yet computed, below the threshold for a reliable figure, or the only source is too old to print. The reason is always given.

Mean field-weighted citation impact

2.17

95% stability interval 2.13 to 2.21 · 51,089 papers with the measure

OpenAlex · OpenAlex years 2021–2024 provisional

Share in the world’s top 10% most cited

24.3%

95% stability interval 23.8% to 24.8% · 51,089 papers with the measure

OpenAlex · OpenAlex years 2021–2024 provisional

03 / ACCESS AND AUTHORSHIP

Open Access, Collaboration & Team Size

Full counting: each paper counts once, whatever its number of authors or countries. Each chart is a share of the papers in this view.

Open-Access Route

Gold: in a fully open-access journal. Diamond: in a fully open-access journal that charges neither readers nor authors. Hybrid: free under an open licence in a subscription journal. Green: in a subscription journal, with a free copy in an open repository. Bronze: free to read on the publisher's site, without an open licence. Closed: no free copy found. Each paper has one route, as OpenAlex records it.

Share of the 67,441 papers with an open-access status recorded · OpenAlex

Gold55% ·
Closed21% ·
Hybrid11% ·
Diamond5% ·
Green5% ·
Bronze3% ·
Team Size

Number of authors on the paper, as bands, in the order of the bands.

1 author6% ·
2–5 authors28% ·
6–10 authors47% ·
11–50 authors19% ·
51–100 authors1% ·
More than 100 authors0% ·

International collaboration

Papers with at least one affiliation outside Saudi Arabia, including the foreign affiliation of an author who also lists a Saudi one. Papers whose affiliations aren't recorded stay in the total and are not counted as international.

72%

of the 67,466 papers

04 / INDUSTRY INVOLVEMENT

Industry Involvement In Papers

Each paper has one of four codes, read from its conflict-of-interest statement, grant list, author affiliations and linked registration under the industry involvement guide. The four codes keep the guide's order.

This publication-side code and the lead sponsor used for clinical trials and observational studies are different measures. They are never combined, and one is not a check on the other.

No statement is never read as no industry link: statements are missing by journal, not by content, so the two are always shown apart. Author ties only is its own value and is not counted as industry-involved. Each code's share is of the 67,466 papers in this view. Applies: year, publication scope and Saudi authorship. Clinical trials and observational studies with an industry lead sponsor are on Clinical Studies And Industry, as separate counts.

Industry involvement in papers is a lower bound.

Industry involvement is identified from the paper's own record and registration; it does not establish financial investment and is a lower bound.

Industry-involved · 2%
Author ties only · 2%
No industry link · 76%
No statement · 20%

* Not final: counts for these years usually rise at later updates, as recent papers are still being added; citation measures change as citations build up. On this page: publications 2025; citation measures 2023–2024.